{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:35:56Z","timestamp":1764858956359,"version":"3.37.3"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["GGPM-2014-050"],"award-info":[{"award-number":["GGPM-2014-050"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.leukres.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T02:02:54Z","timestamp":1495072974000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["MicroRNAs that affect the Fanconi Anemia\/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations"],"prefix":"10.1016","volume":"59","author":[{"given":"E","family":"Yap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZA","family":"Norziha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Simbun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NR","family":"Tumian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SK","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CF","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CL","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.leukres.2017.05.015_bib0005","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/sj.onc.1206942","article-title":"Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias","volume":"22","author":"Shah","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.leukres.2017.05.015_bib0010","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2002-08-2675","article-title":"Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells","volume":"101","author":"Nimmanapalli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.015_bib0015","first-page":"496","article-title":"Genetic and Epigenetic Silencing of MicroRNA -203 Enhances ABL1 and BCR-ABL1 Oncogene Expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.leukres.2017.05.015_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machov\u00e1","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.leukres.2017.05.015_bib0025","article-title":"MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia","volume":"10","author":"Chakraborty","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2017.05.015_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"San","year":"2009","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2017.05.015_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3892\/or.2015.4456","article-title":"The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review)","volume":"35","author":"Di","year":"2016","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.leukres.2017.05.015_bib0040","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3324\/haematol.2009.020636","article-title":"Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia","volume":"95","author":"Flamant","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2017.05.015_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pone.0115003","article-title":"Validating a combined mRNA and MicroRNA signature in response to imatinib treatment in a chronic myeloid Leukemia cell line","volume":"9","author":"Bhutra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2017.05.015_bib0050","unstructured":"National Comprehensive Cancer Network. Chronic Myelogenous Leukemia (Version 1.2015). http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf. Accessed August 13, 2015."},{"key":"10.1016\/j.leukres.2017.05.015_bib0055","article-title":"Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients","volume":"4","author":"Elias","year":"2012","journal-title":"Med. Clin. (Barc)."},{"issue":"1","key":"10.1016\/j.leukres.2017.05.015_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/genes1010070","article-title":"Next generation sequencing of miRNAs \u2212 strategies, resources and methods","volume":"1","author":"Motameny","year":"2010","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.leukres.2017.05.015_bib0065","unstructured":"Command-line tools for processing biological sequencing data [Internet]. [updated 2011; cited Available from: http:\/\/code.google.com\/p\/ea-utils."},{"key":"10.1016\/j.leukres.2017.05.015_bib0070","doi-asserted-by":"crossref","first-page":"D226","DOI":"10.1093\/nar\/gks1005","article-title":"Rfam 11.0: 10 years of RNA families","volume":"41","author":"Burge","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2017.05.015_bib0075","doi-asserted-by":"crossref","first-page":"D93","DOI":"10.1093\/nar\/gkn787","article-title":"GtRNAdb: a database of transfer RNA genes detected in genomic sequence","volume":"37","author":"Chan","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.leukres.2017.05.015_bib0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"issue":"7","key":"10.1016\/j.leukres.2017.05.015_bib0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"issue":"Web Server issue","key":"10.1016\/j.leukres.2017.05.015_bib0090","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gks494","article-title":"DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways","volume":"40","author":"Vlachos","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.leukres.2017.05.015_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2017.05.015_bib0100","first-page":"1","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance","volume":"46","author":"Bixby","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"2","key":"10.1016\/j.leukres.2017.05.015_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2040620712468289","article-title":"Management of imatinib-resistant patients with chronic myeloid leukemia","volume":"4","author":"Bhamidipati","year":"2013","journal-title":"Therapeut. Adv. Hematol."},{"issue":"5531","key":"10.1016\/j.leukres.2017.05.015_bib0110","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.leukres.2017.05.015_bib0115","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.leu.2403426","article-title":"Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance","volume":"18","author":"Hochhaus","year":"2004","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2017.05.015_bib0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","article-title":"BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet","volume":"118","author":"Soverini","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2017.05.015_bib0125","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2006-07-036012","article-title":"Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"109","author":"Picard","year":"2007","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.leukres.2017.05.015_bib0130","first-page":"3504","article-title":"A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells","volume":"60","author":"Sekuli\u0107","year":"2000","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.leukres.2017.05.015_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pone.0068442","article-title":"Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.leukres.2017.05.015_bib0140","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/ijms17040570","article-title":"Downregulation of plasma miR-215 in chronic myeloid leukemia patients with successful discontinuation of imatinib","volume":"17","author":"Ohyashiki","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.leukres.2017.05.015_bib0145","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood.V124.21.3133.3133","article-title":"Identification of new microRNA biomarkers and candidate target genes in primitive CML cells using global comparative RNA analyses","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2017.05.015_bib0150","first-page":"10","article-title":"Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells","volume":"7","author":"Rokah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2017.05.015_bib0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","article-title":"How the fanconi anemia pathway guards the genome","volume":"43","author":"Moldovan","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"5","key":"10.1016\/j.leukres.2017.05.015_bib0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/cas.12652","article-title":"BRCA\/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer","volume":"106","author":"Nakashima","year":"2015","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.leukres.2017.05.015_bib0165","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.173.6.3863","article-title":"Impaired type I IFN-induced Jak\/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-\/- mice","volume":"173","author":"Fagerlie","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.leukres.2017.05.015_bib0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1101\/gad.1761309","article-title":"Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis","volume":"23","author":"Kee","year":"2009","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.leukres.2017.05.015_bib0175","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2008-05-154294","article-title":"ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function","volume":"113","author":"Collins","year":"2009","journal-title":"Blood"},{"issue":"5547","key":"10.1016\/j.leukres.2017.05.015_bib0180","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1065521","article-title":"ATR and ATRIP: partners in checkpoint signaling","volume":"294","author":"Cortez","year":"2001","journal-title":"Science"},{"issue":"35","key":"10.1016\/j.leukres.2017.05.015_bib0185","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.2174\/092986711798194388","article-title":"Extracellular signal-regulated kinases modulate DNA damage response \u2212 a contributing factor to using MEK inhibitors in cancer therapy","volume":"18","author":"Wei","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.leukres.2017.05.015_bib0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12032-015-0554-6","article-title":"PI3K\/AKT\/mTOR pathway is activated after imatinib secondary resistance in gastrointestinal stromal tumors (GISTs)","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.leukres.2017.05.015_bib0195","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2403898","article-title":"Compensatory PI3-kinase\/Akt\/mTor activation regulates imatinib resistance development","volume":"19","author":"Burchert","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2017.05.015_bib0200","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a Fanconi anemia-like disorder","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat. Genet."},{"issue":"19","key":"10.1016\/j.leukres.2017.05.015_bib0205","first-page":"323","article-title":"Hereditary breast and ovarian cancer: new genes, new treatments, new concepts","volume":"108","author":"Meindl","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"10.1016\/j.leukres.2017.05.015_bib0210","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","article-title":"Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis","volume":"22","author":"Slupianek","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"56","key":"10.1016\/j.leukres.2017.05.015_bib0215","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","article-title":"BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability","volume":"21","author":"Skorski","year":"2002","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.leukres.2017.05.015_bib0220","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/nar\/29.7.1534","article-title":"Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells","volume":"29","author":"Collis","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.leukres.2017.05.015_bib0225","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1074\/jbc.M808430200","article-title":"UAF1 is a subunit of multiple deubiquitinating enzyme complexes","volume":"284","author":"Cohn","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.leukres.2017.05.015_bib0230","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.molcel.2007.09.031","article-title":"A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway","volume":"28","author":"Cohn","year":"2007","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.leukres.2017.05.015_bib0235","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1093\/nar\/gku656","article-title":"5' isomiR variation is of functional and evolutionary importance","volume":"42","author":"Tan","year":"2014","journal-title":"Nucleic Acids Research 2014"},{"issue":"11","key":"10.1016\/j.leukres.2017.05.015_bib0240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tig.2012.07.005","article-title":"IsomiRs\u2013the overlooked repertoire in the dynamic microRNAome","volume":"28","author":"Neilsen","year":"2012","journal-title":"Trends Genet."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T06:41:38Z","timestamp":1655620898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"alternative-id":["S0145212617304356"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs that affect the Fanconi Anemia\/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}